CA Stock MarketDetailed Quotes
OMND Optimind Pharma Corp
- 0.005
- 0.0000.00%
15min DelayMarket Closed Jul 16 14:36 ET
598.94KMarket Cap-500P/E (TTM)
0.000High0.000Low0Volume0.000Open0.005Pre Close0.00Turnover0.02552wk High0.00%Turnover Ratio119.79MShares0.00552wk Low-0.01EPS TTM465.76KFloat Cap0.200Historical HighLossP/E (Static)93.15MShs Float0.005Historical Low-0.01EPS LYR0.00%Amplitude--Dividend TTM-5.00P/B1Lot Size--Div YieldTTM
Optimind Pharma Corp Key Stats
Quarterly+Annual
YOY
| (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | (Q3)Nov 30, 2022 | (Q2)Aug 31, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -27.72%122.96K | -35.17%27.66K | -55.42%26.67K | -0.96%27.35K | 3.19%41.27K | 170.11K | 42.67K | 59.83K | 27.62K | 0 |
| Operating revenue | -27.72%122.96K | -35.17%27.66K | -55.42%26.67K | -0.96%27.35K | 3.19%41.27K | --170.11K | --42.67K | --59.83K | --27.62K | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -34.85%889.83K | -11.78%165.9K | -64.97%122.19K | -72.27%183.88K | 152.20%417.86K | 1.37M | 188.06K | 348.83K | 4,417.09%663.2K | 441.58%79.52K |
| Selling and administrative expenses | -26.62%668.98K | 21.46%159.46K | -65.10%101.96K | -58.33%147.37K | 93.42%260.19K | --911.63K | --131.28K | --292.17K | 2,308.77%353.66K | 441.58%79.52K |
| -General and administrative expense | -26.62%668.98K | 21.46%159.46K | -65.10%101.96K | -58.33%147.37K | 93.42%260.19K | --911.63K | --131.28K | --292.17K | 2,308.77%353.66K | 441.58%79.52K |
| Research and development costs | --120K | --0 | --0 | --0 | --120K | --0 | --0 | --0 | --0 | ---- |
| Depreciation amortization depletion | -54.39%19.95K | --0 | -54.39%4.99K | -31.58%7.48K | -31.58%7.48K | --43.74K | --10.94K | --10.94K | --10.94K | ---- |
| -Depreciation and amortization | -54.39%19.95K | --0 | -54.39%4.99K | -31.58%7.48K | -31.58%7.48K | --43.74K | --10.94K | --10.94K | --10.94K | ---- |
| Other operating expenses | -80.29%80.89K | -85.95%6.44K | -66.66%15.25K | -90.28%29.03K | 49.19%30.18K | --410.41K | --45.84K | --45.73K | --298.61K | ---- |
| Operating profit | 35.86%-766.87K | 4.92%-138.24K | 66.95%-95.52K | 75.37%-156.53K | -199.62%-376.58K | -1.2M | -145.4K | -289K | -4,228.98%-635.58K | -441.58%-79.52K |
| Net non-operating interest income (expenses) | -22.81%-91.3K | 55.70%-11.92K | 8.24%-25.34K | -93.63%-26.97K | -358.72%-27.08K | -74.34K | -26.9K | -27.61K | -386.66%-13.93K | -57.82%-4.52K |
| Non-operating interest expense | 22.81%91.3K | -55.70%11.92K | -8.24%25.34K | 93.63%26.97K | 358.72%27.08K | --74.34K | --26.9K | --27.61K | 386.66%13.93K | 57.82%4.52K |
| Other net income (expenses) | 69.83%-548.17K | -564.61K | 16.44K | -1.82M | 683.42%6.02K | |||||
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 683.42%6.02K |
| Special income (charges) | 69.83%-548.17K | 68.93%-564.61K | --16.44K | ---- | ---- | ---1.82M | ---1.82M | --0 | ---- | ---- |
| -Less:Impairment of capital assets | -75.37%371.25K | -74.28%387.69K | ---16.44K | ---- | ---- | --1.51M | --1.51M | --0 | ---- | ---- |
| -Less:Other special charges | ---16.44K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Write off | -37.63%193.36K | ---- | ---- | ---- | ---- | --310K | ---- | ---- | ---- | ---- |
| Income before tax | 54.45%-1.41M | 64.07%-714.77K | 67.02%-104.42K | 71.75%-183.5K | -206.76%-403.66K | -3.09M | -1.99M | -316.61K | -3,396.60%-649.51K | -319.98%-78.01K |
| Income tax | 1.02%-8.76K | -52.22%-8.76K | 0 | 0 | 0 | -8.85K | -5.75K | 0 | 0 | |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 54.60%-1.4M | 64.41%-706.01K | 67.02%-104.42K | 71.75%-183.5K | -214.14%-403.66K | -3.08M | -1.98M | -316.61K | -3,396.60%-649.51K | -319.98%-78.01K |
| Net income continuous operations | 54.60%-1.4M | 64.41%-706.01K | 67.02%-104.42K | 71.75%-183.5K | -214.14%-403.66K | ---3.08M | ---1.98M | ---316.61K | -3,396.60%-649.51K | -319.98%-78.01K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 54.60%-1.4M | 64.41%-706.01K | 67.02%-104.42K | 71.75%-183.5K | -214.14%-403.66K | -3.08M | -1.98M | -316.61K | -3,396.60%-649.51K | -319.98%-78.01K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 54.60%-1.4M | 64.41%-706.01K | 67.02%-104.42K | 71.75%-183.5K | -214.14%-403.66K | -3.08M | -1.98M | -316.61K | -3,396.60%-649.51K | -319.98%-78.01K |
| Diluted earnings per share | 75.00%-0.01 | 88.46%-0.003 | 66.67%-0.001 | 77.78%-0.002 | -100.00%-0.004 | -0.04 | -0.026 | -0.003 | -396.69%-0.009 | -611.09%-0.0129 |
| Basic earnings per share | 75.00%-0.01 | 88.46%-0.003 | 66.67%-0.001 | 77.78%-0.002 | -100.00%-0.004 | -0.04 | -0.026 | -0.003 | -396.69%-0.009 | -611.09%-0.0129 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg